Ardelyx, Inc. (ARDX) vs ArriVent BioPharma, Inc. (AVBP)
- Ardelyx, Inc. ARDX 3.09 −5.50%
- ArriVent BioPharma, Inc. AVBP 16.66 −0.77%
Ardelyx, Inc. and ArriVent BioPharma, Inc. are both Biotechnology companies. Ardelyx, Inc. and ArriVent BioPharma, Inc. are of similar size ($827.9M and $814.9M). ArriVent BioPharma, Inc. has the higher net margin (0.00% vs −12.4%) and the higher return on invested capital (0.00% vs −18.6%). Across the 13 metrics below, ArriVent BioPharma, Inc. leads on 7 and Ardelyx, Inc. on 6.
Valuation
Profitability
| Metric | ARDX | AVBP | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | — | 65.16% |
| Operating margin | (7.86%) | 0.00% | 0.00% |
| Net margin | (12.35%) | 0.00% | 0.00% |
| Free cash flow margin | (3.97%) | 0.00% | 0.00% |
| Return on equity | (38.61%) | (53.10%) | (56.36%) |
| Return on assets | (10.68%) | (49.30%) | (48.04%) |
| Return on invested capital | (18.62%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack